pehub.com -- ProCertus BioPharm Inc., a Madison, Wisc.-based developer of drugs to treat the side effects of chemotherapy and radiotherapy on cancer patients, has raised $2.1 million in new VC funding. Return backers include Novartis Venture Fund and Venture Investors LLC.
